The three-year Swiss-EU dispute over immigration should not leave ‘any doubt’ that EU will make no concessions to UK in Brexit talks, says ERC Council member, Athene Donald
Unlike hip replacements or cataract surgery, treating mental health conditions can be open-ended - and assessing outcomes subjective. But now there is a push to develop standards and enable mental health to join the value-based healthcare revolution
More than a year after the public consultation closed, EMA and the Commission have announced moves that aim to clear the regulatory logjam holding back commercialisation of therapies based on tissues, cells and genes
The apps will improve self-care, adherence to therapy and long-term outcomes in this common, chronic condition, its developers say. The app for healthcare professionals will be one of the first such m-health apps to be CE-approved
Fears that the EU will give up its involvement in health won’t go away. A big concern is that the next president of the Commission “might abolish” its responsibilities, says Austria’s director-general for health
Developing new antibiotics, from the first idea to proof of concept. The German-Australian iCAIR project brings together researchers from Fraunhofer ITEM, the MHH in Hannover and Griffith University in Australia.
CEU claims agreement with US college puts it in compliance with new law. But the government declines to confirm it can continue operating in Budapest. “This should be the source of enormous concern in Europe,” says CEU’s president
‘Keep collaborating,’ EU commissioner tells UK grantees rattled by legal uncertainties over Brexit, while UK science minister argues that government pledge to underwrite funding has steadied UK involvement in EU science
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.